April 20 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG
SANN.S :
* SANTHERA REPORTS INTERIM RESULTS ON CONVERTIBLE BOND
EXCHANGE
OFFER
* SO FAR AN AGGREGATE PRINCIPAL VALUE OF AROUND CHF 39.6
MILLION,
OR 66% OF ITS CHF 60 MILLION CONVERTIBLE BONDS, HAVE BEEN
ACCEPTED FOR EXCHANGE UNDER EXCHANGE OFFER ANNOUNCED ON MARCH
25, 2021
* BONDHOLDERS WHO HAVE NOT YET ACCEPTED EXCHANGE OFFER WILL
BE
ABLE TO DO SO DURING ADDITIONAL ACCEPTANCE PERIOD ENDING ON
APRIL 27, 2021, 5:00 P.M
* BONDHOLDERS HAVE ACCEPTED EXCHANGE OFFER WITH RESPECT TO
2017/22
BONDS WITH AN AGGREGATE PRINCIPAL AMOUNT OF CHF 39,620,000,
CORRESPONDING TO 66.03% OF ALL 2017/22 BONDS IN CIRCULATION
Source text for Eikon: ID:nGNE15Fzy6
Further company coverage: SANN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))